The relationship between Serum ferritin and Osteoporosis

doi:10.3877/cma.j.issn.2096-0263.2020.02.009

Abstract

Abstract:

Objective

To analyze the difference of serum ferritin among postmenopausal women and men older than 50 years with different bone mass, and to explore the correlation between serum ferritin level and bone mineral density (BMD).

Methods

Postmenopausal women (n=131) and men (n=65) older than 50 years who received DEXA from September 2018 to February 2019 were enrolled in this study. They were divided into normal (46 cases), osteopenia (68 cases) and osteoporosis (82 cases) groups. Clinical data and biochemical parameters were collected. The level of serum ferritin was detected, and its correlation with BMDwas also determined.

Results

1．Compared with normal and osteopenia group, serum ferritin level was significantly increased in osteoporosis group [174.25 (160.85, 210.42) ng/ml vs. 99.50 (91.55, 128.51) ng/ml and 103.36 (93.26, 113.46) ng/ml, χ²=100.573, P<0.05]. 2. The level of serum ferritin was negatively correlated with BMD in hip and lumbar spine (hip r=-0.487, P<0.05; lumbar vertebrae r=-0.531, P<0.05). 3. Multivariate binary logistic regression analysis showed that body weight was the protective factor for osteoporosis (r=0.049, P<0.05), and serum ferritin was the risk factor for osteoporosis (r=-0.018, P<0.05).

Conclusion

Serum ferritin plays an important role in the prevalence of osteoporosis, which may be a risk factor for osteoporosis.

Key words: Bone density, Osteoporosis, Iron overload, Serum ferritin

Jingjing Lu, Xing Li, Pingping Lou, Jie Zhang, Yan Liu, Yaru. Zhou. The relationship between Serum ferritin and Osteoporosis[J]. Chinese Journal of Geriatric Orthopaedics and Rehabilitation(Electronic Edition), 2020, 06(02): 111-116.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhlngkykfdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2096-0263.2020.02.009

https://zhlngkykfdzzz.cma-cmc.com.cn/EN/Y2020/V06/I02/111

Figures/Tables 6

References 17

1	Harvey NC, Biver E, Kaufman JM, et al. The role of Calcium supplementation in healthy musculoskeletal ageing:An expert consensus meeting of the European Society for Clinical and Economic Aspects of Osteoporosis,Osteoarthritis and Musculoskeletal Diseases(ESCEO)and the International Foundation for Osteoporosis(IOF) [J]. Osteoporos Int, 2017, 28(2): 447-462.
2	Lin X, Xiong D, Peng YQ, et al. Epidemiology and management of osteoporosis in the People's Republic of China:current perspectives [J]. Clin Interv Aging, 2015, 25(10): 1017-1033.
3	Kim BJ, Lee SH, Koh JM, et al. The association between higher serum ferritin level and lower bone mineral density is prominent in women≥45 years of age(KNHANES 2008-2010) [J]. Osteoporos Int, 2013, 24(10): 2627-2637.
4	Tsay J, Yang Z, Ross FP, et al. Bone loss caused by Iron overload in a murine model: importance of oxidative stress [J]. Blood, 2010, 116(14): 2582-2589.
5	Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group [J]. Osteoporos Int, 1994, 4(6): 368-381.
6	中国健康促进基金会骨质疏松防治中国白皮书编委会. 骨质疏松症中国白皮书[J]. 中华健康管理学杂志, 2009, 3: 148-154.
7	费蓓蓓，王啸，张弘, 等. 雌激素缺乏环境下铁蓄积对骨吸收及破骨细胞分化的影响[J]. 中华骨质疏松和骨矿盐疾病杂志, 2019, 12(02): 151-157.
8	Eleftherios Pelechas, Evripidis Kaltsonoudis, Paraskevi V. Voulgari, Alexandros A. Drosos. Osteoporosis [M]. Springer International Publishing, 2018, 12-29.
9	Pinheiro MM, Reis N. Machado FS, et al. Risk factors for osteoporotic fractures and low bone density in pre and postmenopausal women [J]. Rev Saude Publica, 2010, 44(3): 479-485.
10	柴生颋，谢平金，万雷, 等. 体重及体质量指数与骨质疏松性骨折发生的关系研究[J]. 中国骨质疏松杂志, 2018, 24(02): 156-160.
11	Che J, Yang J, Zhao B, et al. The Effect of Abnormal Iron Metabolism on Osteoporosis [J]. Biol Trace Elem Res, 2019, Aug 31. [Epub ahead of print].
12	Li GF, Pan YZ, Sirois P, et al. Iron homeostasis in osteoporosis and its clinical implications [J]. Osteoporos Int, 2012, 23(10): 2403-2408.
13	Weinberg ED. Iron loading: a risk factor for osteoporosis [J]. Biometals, 2006, 19(6): 633-635.
14	费蓓蓓. 雌激素对"铁蓄积导致骨代谢异常"的影响及作用机制的研究[D]. 苏州: 苏州大学, 2017.
15	15王啸. "铁蓄积"影响骨代谢的临床观察及分子机制[D]. 苏州: 苏州大学, 2018.
16	Galli C, Passeri G, Macaluso GF. Wnts and oxidative stress-induced bone loss: new players in the periodontitis arena? [J]. J Periodontal Res, 2011, 46(4): 397-406.
17	Sun H, Huang Z, Wu P, et al. CDK6 and miR-320c Co-Regulate chondrocyte catabolism through NF-κB signaling pathways [J]. Cell Physiol Biochem, 2018, 51(2): 909-923.

组别	例数	性别（男性/女性）	年龄（岁， ±s）	BMI（kg/m², ±s)	ALP[U/L,M(Q_R)]	Ca（mmol/L, ±s)	P（mmol/L, ±s)
骨量正常组	46	19/29	62±10	26.0±2.8	68.26(57.84,81.29)	2.28±0.08	1.16±0.15
骨量减少组	68	27/41	65±9	26.0±3.4	67.35(55.27,79.41)	2.29±0.07	1.14±0.18
骨质疏松组	82	19/63	66±9	24.6±3.2	69.98(56.19,78.52)	2.26±0.09	1.18±0.11
Z值		6.350	7.910	2.778	7.231	0.831	0.639
P值		0.052	0.069	0.065	0.329	0.267	0.325

组别	例数	性别（男性/女性）	年龄（岁， ±s）	BMI（kg/m², ±s)	ALP[U/L,M(Q_R)]	Ca（mmol/L, ±s)	P（mmol/L, ±s)
骨量正常组	46	19/29	62±10	26.0±2.8	68.26(57.84,81.29)	2.28±0.08	1.16±0.15
骨量减少组	68	27/41	65±9	26.0±3.4	67.35(55.27,79.41)	2.29±0.07	1.14±0.18
骨质疏松组	82	19/63	66±9	24.6±3.2	69.98(56.19,78.52)	2.26±0.09	1.18±0.11
Z值		6.350	7.910	2.778	7.231	0.831	0.639
P值		0.052	0.069	0.065	0.329	0.267	0.325

组别	例数	血清铁蛋白[ng/ml，M(Q_R)]
骨量正常组	46	99.50(91.55,128.51)
骨量减少组	68	103.36(93.26,113.46)
骨质疏松组	82	174.25(160.85,210.42)^*#
χ²值		100.573
P值		<0.01

组别	例数	血清铁蛋白[ng/ml，M(Q_R)]
骨量正常组	46	99.50(91.55,128.51)
骨量减少组	68	103.36(93.26,113.46)
骨质疏松组	82	174.25(160.85,210.42)^*#
χ²值		100.573
P值		<0.01

组别	例数	血清铁蛋白[ng/ml，M(Q_R)]
50～59岁	37	123.20(94.60,140.60)
60～69岁	58	130.90(89.77,187.47)
70岁以上	36	136.65(98.28,212.28)*
χ²值		51.79
P值		0.045

Please choose a citation manager

Content to export